Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Search for other papers by Carlo Cappelli in
Google Scholar
PubMed
Search for other papers by Cristina Ciuoli in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Search for other papers by Francesco Chiofalo in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Paola Palmitesta in
Google Scholar
PubMed
Search for other papers by Luca Chiovato in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
: Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology. Head Neck 2015;37:260-264. 10.1002/hed.23587 24375752 33 Sachmechi I, Miller E, Varatharajah R, Chernys A, Carroll Z, Kissin E, Rosner F
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Alexander Gorshtein in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Ilana Slutzky-Shraga in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Eyal Robenshtok in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Carlos Benbassat in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Dania Hirsch in
Google Scholar
PubMed
. Nodules are divided into 6 diagnostic categories with different implied risk of malignancy (ROM) and clinical management guidelines [ 1 ]. According to the original classification, Bethesda III (B3) nodules have a relatively low (5–15%) ROM and might be
Search for other papers by Hélène Théodon in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Johanna Wassermann in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Loïc Jaffrelot in
Google Scholar
PubMed
Search for other papers by Jérome Denis in
Google Scholar
PubMed
Search for other papers by Nathalie Chereau in
Google Scholar
PubMed
Search for other papers by Claude Bigorgne in
Google Scholar
PubMed
Search for other papers by Wiame Potonnier in
Google Scholar
PubMed
Search for other papers by Florence Coulet in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
needle aspirates can be used to infer the risk of malignancy in indeterminate thyroid nodules ( 6 , 7 , 8 ) and for genetic analysis in other types of cancers such as pancreatic cancers ( 9 ). For thyroid cancer patients, when FFPE tumoral tissue is
Search for other papers by Roussanka D. Kovatcheva in
Google Scholar
PubMed
Search for other papers by Alexander D. Shinkov in
Google Scholar
PubMed
Search for other papers by Inna D. Dimitrova in
Google Scholar
PubMed
Search for other papers by Ralitsa B. Ivanova in
Google Scholar
PubMed
Search for other papers by Kalin N. Vidinov in
Google Scholar
PubMed
Search for other papers by Radina S. Ivanova in
Google Scholar
PubMed
estimated risk of malignancy (ROM) in category 2 is close to zero, in category 3, 2–4%, in category 4, 6–17%, and in category 5, 26–87%. Unlike EU-TIRADS, the US malignancy risk stratification system of the American College of Radiology (ACR-TIRADS) is score
Center for Genomic Research, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Maria Laura Monzani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Search for other papers by Antonino Maiorana in
Google Scholar
PubMed
Search for other papers by Stefania Bettelli in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Valeria Moriondo in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Lara Bonacini in
Google Scholar
PubMed
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Center for Genomic Research, Italy
Azienda USL of Modena, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
molecular diagnosis in thyroid cancer patients. Among THY2 samples, the BRAF+ rate (1.2%) was higher than in previous studies [ 20 , 23 ], but concordant with the known estimated risk of malignancy of 0-3% [ 24 ]. Cytological FN rates are underestimated
Search for other papers by Dulani Kottahachchi in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, VIC, Australia
Search for other papers by Duncan J. Topliss in
Google Scholar
PubMed
]. Association with Malignancy Although pancreatic adenocarcinoma [ 52 ], non-Hodgkin lymphoma [ 53 ], and salivary duct cancer [ 54 ] have been linked to IgG4-RD, the actual risk of malignancy is unknown. Studies on the effect of IgG4-positive cells on cancer
Search for other papers by M Grussendorf in
Google Scholar
PubMed
Search for other papers by I Ruschenburg in
Google Scholar
PubMed
Search for other papers by G Brabant in
Google Scholar
PubMed
high rate of cytological clarification in almost half of all patients. Our data allow a more precise estimation of the risk of malignancy in TN >1 cm patients first confronted with the diagnosis of a thyroid nodule and provide a more detailed insight
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
Search for other papers by Milan Halenka in
Google Scholar
PubMed
Search for other papers by Hana Munteanu in
Google Scholar
PubMed
Search for other papers by Radko Obereigneru in
Google Scholar
PubMed
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
Search for other papers by Roman Dohnal in
Google Scholar
PubMed
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
Search for other papers by David Karasek in
Google Scholar
PubMed
Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
Search for other papers by Jan Schovanek in
Google Scholar
PubMed
fluid volume exceeds 90% ( 3 ). The fraction of predominantly cystic or cystic nodules is 15–25% ( 4 ). The estimated risk of malignancy is <1% for pure cysts and <3% for spongiform and complex nodules with a cystic component ( 5 ). About 5% of the
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
risk of malignancy . Endocrine 2018 61 303 – 307 . ( https://doi.org/10.1007/s12020-018-1634-0 ) 15 R Core Team . R: A Language and Environment for Statistical Computing . Vienna, Austria : R Foundation for Statistical Computing , 2016 . 16
Search for other papers by Chantal A Lebbink in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Renuka P Dias in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Search for other papers by Heiko Krude in
Google Scholar
PubMed
Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Arnoldo Piccardo in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Toru Takano in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
low recurrence rate and to minimize adverse effects of treatment) will be reached (4S). [B] Recommendations and suggestions for the pediatric thyroid nodule [B2] 3A 3B Risk of malignancy in thyroid nodule during childhood We recommend